Moves to safeguard consumer interests around PCR testing welcomed
Randox has responded to a recent announcement on PCR testing by the Consumer and Markets Authority (CMA).
A spokesperson for Randox said: “We welcome the role played by the CMA, with our full cooperation, in ensuring that consumers continue to get a fair deal during the COVID emergency.
“Randox has been happy to engage fully with the CMA from the outset to ensure in the interests of its customers while the company delivers millions of COVID-19 PCR tests to facilitate vital international travel against the changing requirements of governments.
“As the industry leader, Randox has been in the ideal position to both review the services required to support the international traveller and provide a consumer-industry standard of Terms and Conditions. These have, of necessity, evolved over time.
“In working with the CMA, Randox’s aim has been to ensure absolute fairness whilst building and providing critical services in a highly volatile and demanding environment.”
Click on the link below for the full statement.
Other News
Featured Supplier
Upcoming Events
analytica 2022
Messe München, Germany
June 21-24, 2022
The Genomic and Microbiology Revolution: In Technology We Trust?
Royal Air Force Museum, Hendon, London
19 July 2022
Arab Lab Live 2022
Dubai International Convention & Exhibition Centre Dubai World Trade Centre - Trade Centre - Trade Centre 2 - Dubai - United Arab Emirates
24 - 26 October 2022
Lab Innovations 2022
Hall 2 NEC, Birmingham
2 & 3 November 2022
MEDICA 2022
Messe Düsseldorf D-40474 Düsseldorf, Stockumer Kirchstraße 61
14 - 17 November 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store